Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.270
+0.010 (0.79%)
Nov 22, 2024, 4:00 PM EST - Market closed
Allarity Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
1.79M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
cbdMD | 20.64M |
iCoreConnect | 11.05M |
Akanda | 2.51M |
Tivic Health Systems | 957.00K |
Helius Medical Technologies | 502.00K |
60 Degrees Pharmaceuticals | 462.61K |
Aclarion | 49.29K |
ALLR News
- 4 days ago - Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements - GlobeNewsWire
- 11 days ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - Accesswire
- 11 days ago - DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm - Accesswire
- 12 days ago - The Schall Law Firm Urges Shareholders In Allarity Therapeutics, Inc. To Join A Securities Fraud Case - Accesswire
- 13 days ago - Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm - Accesswire
- 14 days ago - ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 14 days ago - The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Allarity Therapeutics, Inc. - Accesswire
- 14 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - PRNewsWire